You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Monarch Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for MONARCH PHARMS, and what generic and branded alternatives to MONARCH PHARMS drugs are available?

MONARCH PHARMS has twenty-two approved drugs.



Summary for Monarch Pharms
US Patents:0
Tradenames:17
Ingredients:14
NDAs:22

Drugs and US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Monarch Pharms NEOSPORIN G.U. IRRIGANT neomycin sulfate; polymyxin b sulfate SOLUTION;IRRIGATION 060707-001 Approved Prior to Jan 1, 1982 AT RX No Yes ⤷  Sign Up ⤷  Sign Up
Monarch Pharms CORTISPORIN hydrocortisone; neomycin sulfate; polymyxin b sulfate SOLUTION/DROPS;OTIC 050479-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Monarch Pharms CORTISPORIN bacitracin zinc; hydrocortisone; neomycin sulfate; polymyxin b sulfate OINTMENT;TOPICAL 050168-002 May 4, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up
Monarch Pharms VIROPTIC trifluridine SOLUTION/DROPS;OPHTHALMIC 018299-001 Approved Prior to Jan 1, 1982 AT RX Yes Yes ⤷  Sign Up ⤷  Sign Up
Monarch Pharms DERMACORT hydrocortisone CREAM;TOPICAL 083011-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
Monarch Pharms MENEST estrogens, esterified TABLET;ORAL 084948-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Monarch Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Monarch Pharms QUIBRON-T/SR theophylline TABLET, EXTENDED RELEASE;ORAL 087563-001 Jun 21, 1983 4,465,660 ⤷  Sign Up
Monarch Pharms SEPTRA DS sulfamethoxazole; trimethoprim TABLET;ORAL 017376-002 Approved Prior to Jan 1, 1982 4,209,513 ⤷  Sign Up
Monarch Pharms SEPTRA sulfamethoxazole; trimethoprim TABLET;ORAL 017376-001 Approved Prior to Jan 1, 1982 4,209,513 ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.